Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis Pneumococcal Vaccine”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Large-scale testing (Phase 3)Study completedNCT00169507
What this trial is testing

Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)

Who this might be right for
Prophylaxis Pneumococcal Vaccine
GlaxoSmithKline 100
Large-scale testing (Phase 3)Study completedNCT00427895
What this trial is testing

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Who this might be right for
Pneumococcal Infections
Pfizer 2,141
Large-scale testing (Phase 3)Study completedNCT00688870
What this trial is testing

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Who this might be right for
VaccinesPneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer 168
Post-approval studies (Phase 4)Study completedNCT00744263
What this trial is testing

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Who this might be right for
Pneumonia, PneumococcalPneumococcal Infections13-valent Pneumococcal Vaccine
Pfizer 84,496
Post-approval studies (Phase 4)Study completedNCT00316654
What this trial is testing

Persistence of Antibody Response to N. Meningitidis Group C in Children

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 489
Early research (Phase 1)Study completedNCT00327665
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 335
Large-scale testing (Phase 3)Study completedNCT01432262
What this trial is testing

13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Who this might be right for
Pneumococcal Infections
Pfizer 324
Not applicableStudy completedNCT02266277
What this trial is testing

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Who this might be right for
InfluenzaInfections, Pneumococcal
University of Massachusetts, Worcester 30,000
Testing effectiveness (Phase 2)Study completedNCT00307528
What this trial is testing

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Who this might be right for
Prophylaxis Invasive Pneumococcal Diseases and Pneumonia
GlaxoSmithKline 146
Not applicableStudy completedNCT02133469
What this trial is testing

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae

Who this might be right for
Streptococcal PneumoniaNasopharyngeal DiseasesVaccination Adverse Event
Centers for Disease Control and Prevention, China 3,281
Early research (Phase 1)Study completedNCT00873431
What this trial is testing

Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47

Who this might be right for
Pneumococcal Infections
Valneva Austria GmbH 32
Large-scale testing (Phase 3)Ended earlyNCT00119743
What this trial is testing

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

Who this might be right for
Hepatitis A
GlaxoSmithKline 5,000
Post-approval studies (Phase 4)Study completedNCT00294294
What this trial is testing

Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa

Who this might be right for
Vaccines, PneumococcalInfantFever, Chemically Induced+1 more
Wyeth is now a wholly owned subsidiary of Pfizer 300
Very early researchStudy completedNCT03449459
What this trial is testing

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Shanghai Zhongshan Hospital 144
Large-scale testing (Phase 3)Study completedNCT00378417
What this trial is testing

Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes

Who this might be right for
Otitis MediaPneumococcal Infections
Finnish Institute for Health and Welfare 3,075
Testing effectiveness (Phase 2)Study completedNCT00307008
What this trial is testing

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Who this might be right for
Streptococcus Pneumoniae Vaccines
GlaxoSmithKline 1,198
Post-approval studies (Phase 4)Study completedNCT02034877
What this trial is testing

13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India

Who this might be right for
Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC
Pfizer 1,200
Early research (Phase 1)Study completedNCT07059182
What this trial is testing

Safety Study of a Single Dose of Pneumococcal Whole-Cell Vaccine in Healthy Adults

Who this might be right for
PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASEPrevention of Pneumococcal-induced Acute Otitis Media
Serum Life Science Europe GmbH 30
Not applicableStudy completedNCT00227188
What this trial is testing

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Who this might be right for
Invasive Pneumococcal Disease
Pfizer 408
Post-approval studies (Phase 4)Study completedNCT02124161
What this trial is testing

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

Who this might be right for
PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE
Pfizer 882
Load More Results